Vestal Point Capital’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.8M | Buy |
2,000,000
+874,448
| +78% | +$9.96M | 1.2% | 33 |
|
|
2025
Q1 | $13.4M | Buy |
1,125,552
+640,552
| +132% | +$7.61M | 0.95% | 34 |
|
|
2024
Q4 | $9.14M | Buy |
485,000
+60,000
| +14% | +$1.13M | 0.54% | 45 |
|
|
2024
Q3 | $9.55M | Sell |
425,000
-75,000
| -15% | -$1.69M | 0.72% | 33 |
|
|
2024
Q2 | $10.4M | Buy |
+500,000
| New | +$10.4M | 0.78% | 34 |
|